Viewing Study NCT06861894


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-01-26 @ 2:04 AM
Study NCT ID: NCT06861894
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-15
First Post: 2025-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC
Sponsor: Zhigang Li
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Squamous Cell Carcinoma View
Keywords: